Page 103 - புதியது ப்ராடக்ட்ஸ் மற்றும் சேவைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from புதியது ப்ராடக்ட்ஸ் மற்றும் சேவைகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In புதியது ப்ராடக்ட்ஸ் மற்றும் சேவைகள் Today - Breaking & Trending Today

Conway Corporation Deploys Enghouse Networks IPTV Platform To Strengthen Service Offering In All Market Segments

Press release content from PR Newswire. The AP news staff was not involved in its creation.
Conway Corporation Deploys Enghouse Networks IPTV Platform To Strengthen Service Offering In All Market Segments
March 2, 2021 GMT
MARKHAM, ON, March 2, 2021 /PRNewswire/ - Enghouse Networks is pleased to announce Conway Corporation has leveraged the Enghouse EspialTV SaaS platform to strengthen their delivery of TV services to their customers.
The Enghouse IPTV SaaS platform transforms TV services for operators, enabling seamless delivery across set-top boxes, media players and mobile devices. This ensures operators can include TV services that are compelling for consumers, highly cost efficient for the operator and continuously updated to maintain relevance. ....

Enghouse Espialtv Saa , Mick Mccluskey , Jason Hansen , Network Infrastructure , Conway Corp , Enghouse Systems Ltd , Enghouse Networks , Vp Product At Enghouse Networks , Conway Corporation , Arkansas Based Conway Corp , Business Support Systems , Operations Support Systems , Digital Transformation , Enghouse Systems , Products And Services , Consumer Products And Services , Cloud Computing Services , Media And Entertainment Industry , Software Industry , Pr Newswire , Television Industry , New Products And Services , Media Industry , Internet Technology , Communication Technology , Web Services ,

FDA Approves Investigational New Drug (IND) for Neuroendocrine Tumors from Molecular Targeting Technologies, Inc.

Press release content from Business Wire. The AP news staff was not involved in its creation.
FDA Approves Investigational New Drug (IND) for Neuroendocrine Tumors from Molecular Targeting Technologies, Inc.
March 2, 2021 GMT
WEST CHESTER, Pa. (BUSINESS WIRE) Mar 2, 2021
Molecular Targeting Technologies, Inc. (MTTI), a clinical stage radiopharmaceutical therapy company focused on therapies for rare diseases, announced today the approval of an Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA). It enables a Phase I clinical study of the Safety and Dosimetry of its lead product, EBTATE ( 177 Lu-DOTA-EB-TATE), in patients with neuroendocrine tumors (NET). ....

United States , Chris Pak , Clinical Research Organization Newtown , Molecular Targeting Technologies Inc , National Institutes Of Health , Drug Administration , Targeting Technologies , Investigational New Drug , Precision Medicine , Targeted Radionuclide , National Institutes , Cell Thyroid , Clinical Research Organization , Molecular Targeting Technologies , Business Wire , Products And Services , Drug Approvals , Product Approvals , Product Testing , Diagnosis And Treatment , Health Care Industry , New Products And Services , Medical Biotechnology Industry , Clinical Trials , Medical Research , Drug Trials ,

Metro Supply Chain Group Completes Strategic Investment in Defence Logistics Company HCL Logistics

Press release content from PR Newswire. The AP news staff was not involved in its creation.
Metro Supply Chain Group Completes Strategic Investment in Defence Logistics Company HCL Logistics
March 2, 2021 GMT
This investment further enhances Metro Supply Chain Group’s regulated supply chain sector
TORONTO, March 2, 2021 /PRNewswire/ - Metro Supply Chain Group Inc., a North American leader in end-to-end supply chain logistics solutions, announced today a strategic investment in HCL Logistics Inc. and HCL Transport Inc. (collectively, “HCL Logistics”), a contract logistics company specializing in defence and industrial sectors, headquartered in London, Ontario.
ADVERTISEMENT
“With this important investment, Metro Supply Chain Group is building on our proven leadership, ingenuity and quality services to clients with complex requirements, while deepening our capabilities in the defence sector,” said Chiko Nanji, Group Chairman of Metro Supply Chain Gr ....

United States , City Of , United Kingdom , Tim Van Holst , Martin Graham , Franco Barbon , Chiko Nanji , Logistics Inc , Canadian Armed , Metro Supply Chain Group Inc , Metro Supply Chain Group , Canadian Army , Supply Chain Group Inc , North American , Group Chairman , Metro Supply Chain , Canadian Forces , Allied Forces , Group President , Supply Chain Group , Honorary Colonel , Canadian Armed Forces , Intelligence Regiment , Defence Associations , Capital Partners , North America ,

MannKind Corporation to Participate in H.C. Wainwright Global Life Sciences Conference

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
MannKind Corporation to Participate in H.C. Wainwright Global Life Sciences Conference
MannKindMarch 2, 2021 GMT
WESTLAKE VILLAGE, Calif., March 02, 2021 (GLOBE NEWSWIRE) MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will present at the H.C. Wainwright Global Life Sciences Conference which will be available on demand starting on March 9, 2021 at 7:00 am (ET). Interested parties can access a link to the on demand webcast of the presentation from the Events & Presentations section of the Company’s website at http://www.mannkindcorp.com. The webcast replay will remain available for 14 days following the live presentation. ....

United States , Westlake Village , Michael Castagna , Mannkind Corporation , Company Contact , Hc Wainwright Global Life Sciences Conference , Mannkind Corporation Nasdaq , Kind Corporation , Chief Executive Officer , Global Life Sciences Conference , Inhalation Powder , Globe Newswire , Corporate News , New Products And Services , Products And Services , ஒன்றுபட்டது மாநிலங்களில் , வெஸ்ட்லேக் கிராமம் , மைக்கேல் காஸ்டஞ , நிறுவனம் தொடர்பு , ஹ்ஸீ வேந்‌ரைட் உலகளாவிய வாழ்க்கை அறிவியல் மாநாடு , கைஂட் நிறுவனம் , தலைமை நிர்வாகி அதிகாரி , உலகளாவிய வாழ்க்கை அறிவியல் மாநாடு , பெருநிறுவன செய்தி , புதியது ப்ராடக்ட்ஸ் மற்றும் சேவைகள் , ப்ராடக்ட்ஸ் மற்றும் சேவைகள் ,

ParkOhio Announces Fourth Quarter and Full Year 2020 Results

Press release content from Business Wire. The AP news staff was not involved in its creation.
ParkOhio Announces Fourth Quarter and Full Year 2020 Results
March 2, 2021 GMT
CLEVELAND, OHIO (BUSINESS WIRE) Mar 2, 2021
Park-Ohio Holdings Corp. (NASDAQ: PKOH) today announced its results for the fourth quarter and full year 2020.
Matthew V. Crawford, Chairman and Chief Executive Officer, stated, “We are pleased to have ended the year with continued strengthening in the performance of our diversified business. Despite the challenges of last year, 2020 will be remembered as the year during which we realigned our business and created a stronger foundation for future growth. Our areas of greatest focus included lowering our cost to serve our global customer base and refining our allocation of capital towards our most strategic products and services. While we continue to see the lingering effects of the pandemic, we are positioned to see improving sales and quality o ....

United States , Matthewv Crawford , Company Annual Report On Form , Ohio Holdings Corp , European Union , Debt Service Ratio , Assembly Components , Ohio Holdings , Chief Executive Officer , Supply Technologies , Engineered Products , Annual Report , Ended December , Months Ended December , Transition Tax , Park Ohio Holdings , Business Wire , Products And Services , Coronavirus Pandemic , Consumer Products And Services , Corporate Credit , Automobile Manufacturing , Transportation And Shipping , Production Facilities , Lung Disease , New Products And Services ,